Literature DB >> 31436890

Impact of margin status on survival after surgery for sinonasal squamous cell carcinoma.

Aria Jafari1, Sarek A Shen2, Jesse R Qualliotine1, Ryan K Orosco1,3, Joseph A Califano1,3, Adam S DeConde1.   

Abstract

BACKGROUND: Sinonasal squamous cell carcinoma (SNSCC) is the most common malignancy of the paranasal sinuses. Surgery is the mainstay of treatment, yet positive surgical margins (PSM) are common and the prognostic impact on overall survival (OS) is mixed. Given the heterogeneity of impact of PSM on OS within the literature, we hypothesized that extent of tumor extirpation (microscopic PSM vs macroscopic PSM) may play a role in OS.
METHODS: Patients with SNSCC were identified in the National Cancer Database (NCDB, n = 7808). Of these, 4543 patients underwent surgery, 3265 patients underwent nonsurgical therapy. Kaplan-Meier curves were used to compare OS between negative surgical margin (NSM), micro-PSM, and macro-PSM cohorts vs patients undergoing primary nonsurgical therapy in a propensity-score-matched analysis. Multivariable analysis of factors associated with macro-PSM was also performed.
RESULTS: One thousand thirty-three (22.0%) of the surgery patients had PSM, and approximately half (n = 521, 50.6%) of these had macro-PSM. When compared with nonsurgical treatment, propensity-score-matched results demonstrated improved OS in patients with NSM and micro-PSM (p < 0.001), but macro-PSM patients did not demonstrate improvement (p = 0.20). Tumor within the paranasal sinuses and advanced nodal classification (N2/N3) (odds ratio [OR], 1.18; p = 0.02; and OR, 15.09; p = 005, respectively) was associated with increased odds of macro-PSM on multivariable analysis.
CONCLUSION: We demonstrate that the degree of tumor extirpation correlates with OS. Macro-PSM did not confer a benefit to OS when compared with nonsurgical therapy, and factors including tumor location and advanced nodal status affect whether surgery will result in macro-PSM. Given these findings, informed, shared decisionmaking between patient and surgeon regarding nonsurgical alternatives should occur before electing to proceed with surgery in SNSCC.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  margins; oncologic outcomes; quality of life; sinonasal malignancy; sinonasal squamous cell carcinoma; skull base surgery

Mesh:

Year:  2019        PMID: 31436890     DOI: 10.1002/alr.22415

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  3 in total

1.  Endoscopic Fluorescence-Guided Surgery for Sinonasal Cancer Using an Antibody-Dye Conjugate.

Authors:  Zachary P Hart; Naoki Nishio; Giri Krishnan; Guolan Lu; Quan Zhou; Shayan Fakurnejad; Peter John Wormald; Nynke S van den Berg; Eben L Rosenthal; Fred M Baik
Journal:  Laryngoscope       Date:  2019-12-19       Impact factor: 3.325

2.  Outcomes of Management of Sinonasal Malignancies at a Dedicated Cancer Institution: A Retrospective Study.

Authors:  Rahim Dhanani; Muhammad Faisal; Hamza Shahid; Kashif Iqbal Malik; Arif Jamshed; Raza Hussain
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

3.  Treatment Outcomes of Maxillary Sinus Squamous Cell Carcinoma at a Dedicated Cancer Institute: A Retrospective Study.

Authors:  Ahmed A Keerio; Muhammad U Qayyum; Alina Kashif; Rahim Dhanani; Asma Rashid; Muhammad Faisal; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.